Every year, World Toilet Day is observed to raise awareness about the global sanitation crisis and encourage action to solve it. The goal set by the United Nation is to achieve safe toilets for all by 2023, as a part of their Sustainable Development Goals.
The UN also states that 3.5 billion people live without proper sanitation and many children also lose their lives due to poor sanitation and unsafe water. This is why World Toilet Day is observed to raise awareness on this issue.
This year, the theme for World Toilet Day 2024 is "Toilets - A Place for Peace'. This focuses on the growing threat to sanitation that is caused by conflict, climate change, disaster and neglect. When there is a threat to using toilets, it can lead to many health risks.
Not using toilets for too long may lead to Urinary Tract Infection or UTI. For many who do not have access to clean toilets do not drink enough liquid or hold pee for too long. Doctors suggest that holding in pee for too long can cause bacteria to multiply and lead to UTI. By not drinking enough water, your bladder fails to tell the body to pee often, and can cause the bacteria to spread through the urinary tract, which can lead to infection.
Holding in pee for too long can also cause your bladder to stretch, making it difficult or even impossible for the bladder to contract and release pee normally. It can also damage your pelvic floor muscles or could lead to kidney stones.
To prevent such conditions, it is important that everyone has access to clean and safe toilets. In terms of history, the day was established in 2001, by the World Toilet Organization (WTO), which was founded by Jack Sim. However, it was officially recognised by the UN in 2013. The Government of Singapore worked with WTO to create the first UN resolution called Sanitation for All.
India too promotes safe and hygiene toilet through its Swachh Bharat Yojna.
Credit: ProPublica
Raw milk is often promoted as a natural alternative to pasteurized milk. But unpasteurized milk can carry harmful bacteria, including E. coli, Salmonella and Campylobacter.
Two young girls in California — 17-month-old Brooklyn and 6-year-old Victoria — were hospitalized with severe E. coli infections after drinking raw goat milk from the same farm, ProPublica reported.
Brooklyn developed hemolytic uremic syndrome (HUS), a potentially life-threatening complication of E. coli infection, and nearly died.
Doctors suspected the raw milk was the source of the infections.
Brooklyn’s mother, Emily Marris, had been looking for an alternative to formula after breastfeeding her daughter for a year. As she could not continue breastfeeding due to a medication for chronic hip pain, she tried cow’s milk, which left Brooklyn with constipation.
Marris was then guided to raw goat milk in a Facebook group run by her chiropractor.
Members recommended it, claiming goat milk was easier to digest. The group also directed her to MoonLight Ridge Farm.
Also read: Unsafe Sleep Factors Linked To 73% Of Sudden Unexpected Infant Deaths In US: CDC
Brooklyn drank the raw milk for about six months. But on June 2, Brooklyn suddenly began vomiting. Her condition rapidly worsened and she was transferred to Rady Children’s Hospital in San Diego.
Doctors diagnosed her with hemolytic uremic syndrome (HUS), in which blood clots damage small blood vessels and can cause kidney failure.
A stool test confirmed E. coli O157:H7. Doctors suspected the raw milk was the likely source.
Brooklyn required intensive care, including a breathing tube and dialysis. Her condition became so severe that her parents feared she would not survive. She also went into cardiac arrest three times.
E. coli can live in animal intestines and contaminate milk through fecal matter. Even a small amount can cause infection.
Brooklyn was not the only child affected. Six-year-old Victoria, who had also consumed milk from the same farm, was treated at the same San Diego hospital for a severe E. coli infection and required blood transfusions.
There are more children suffering from severe infections after drinking raw milk. In the past two years alone, hundreds had fallen ill across nine states from drinking raw milk or eating products made with it, as social media influencers and President Donald Trump’s White House continue to promote the unproven benefits of raw milk and downplaying its risks.
Read More: Are GLP-1 Drugs Safe for Children? Study Finds Nutritional Deficiency in Nearly 17% Within a Year
California regulates raw-milk sales, but ProPublica reported the farm sold unlabeled milk without the required license. However, on August 1, the Food and Agriculture Department found that the farm had sold unapproved raw milk without a CDFA license. It was not penalized, the report said.
After leaving the hospital, Brooklyn required physical therapy and experienced problems with walking and sleep. Her mother said her development had stalled.
Doctors also warned of possible long-term kidney problems and advised regular nephrology follow-up.
Raw milk is milk that has not been pasteurized. Pasteurization uses heat to destroy harmful bacteria and other pathogens.
Raw-milk proponents often claim that pasteurization destroys nutrients or improves the health benefits of milk. However, experts say pasteurization does not significantly alter milk’s mineral or protein content.
Claims that raw milk improves digestion or boosts immunity have not been scientifically established.
Raw milk can be contaminated through:
Animals: E. coli, Salmonella and Campylobacter can enter milk through infected animals or fecal contamination.
Environment and equipment: Polluted water, dirt, manure and contaminated milking equipment can also introduce pathogens.
Raw milk can cause diarrhea, stomach cramps, nausea and fever. In some cases, infections can become severe or life-threatening.
Children, older adults, pregnant women and people with weakened immune systems are particularly vulnerable.
Certain E. coli infections can cause HUS, which may lead to kidney failure and other serious complications.
Pasteurization destroys harmful bacteria while preserving the nutritional value of milk. The FDA, CDC and American Academy of Pediatrics advise against consuming raw milk because of its foodborne infection risks.
Credit: iStock
Ten batches of medicines used for seizures, heart conditions, depression and postpartum bleeding have been withdrawn at New Delhi’s Dr Ram Manohar Lohia Hospital after quality failures and physical defects were identified.
According to The Times of India, the affected medicines include sodium valproate, spironolactone, imipramine, metoprolol and methyl ergometrine. Some batches were classified as “Not of Standard Quality” after testing, while others showed physical defects.
Which Medicines Were Recalled?
A September 14 notice from RML Hospital said three tablet batches had failed analytical testing:
Five injectable batches were also recalled after failing quality tests. They included:
The hospital had separately flagged physical defects in two tablet batches, the report said.
Also read: 2 Indians Charged In US Over Fake Ozempic Scheme: How To Spot Counterfeit GLP-1 Drugs
A September 9 notice said isosorbide mononitrate 20 mg tablets were found in powder form inside their strips.
The affected batch, ABT6711, was manufactured by Glowson India Labs in July 2026 and expires in June 2028. Departments were told to stop using and return the batch.
A similar defect was found in metoprolol 50 mg tablets from batch ABT6608, also manufactured by Glowson India Labs. The hospital ordered its withdrawal.
RML officials said the affected medicines were recalled after test results were received, with departments instructed to stop using them and report any patient-related problems.
Some medicines were supplied by Jackson Laboratories, according to the hospital.
No severe adverse effects had been reported among patients in connection with the affected batches, officials said. The hospital has also arranged alternative medicines to prevent disruption in treatment.
“The hospital has made interim arrangements to ensure the availability of alternative medicines and avoid any disruption in patient care. The situation is being closely monitored, and all necessary measures are being taken in accordance with established drug quality and patient-safety protocols,” RML official said, TOI reported.
Poor quality drugs can have a severe impact on health which includes death, disease progression, drug resistance and so on.
Poor quality drugs can contain toxic ingredients or incorrect active ingredients that can lead to death. It can also make chronic and infectious diseases worse. Furthermore, these drugs can lead to drug resistance and can threaten the health of people who are consuming them.
It can also cause side effects like rashes, hive, and other health risks, leading to further increasing the health care cost, and leading to loss of income. It can also lead to people's loss of faith in the healthcare system.
Do not stop an essential prescription medicine on your own. Check the medicine name, strength, batch number and expiry date, and contact your doctor or pharmacist if you have a recalled batch.
Seek urgent medical care for serious symptoms such as difficulty breathing, swelling, severe allergic reactions, loss of consciousness or seizures.
Credit: iStock
More American women are starting GLP-1 medications such as Ozempic and Zepbound after giving birth, according to a new study
The findings, published in JAMA, found that the sharpest increases were seen among women with diabetes, obesity or overweight.
Researchers from the University of Southern California Schaeffer Center for Health Policy & Economics analyzed private insurance claims covering just over 1 million births over seven years.
They found that the share of new mothers starting a GLP-1 prescription within six months of childbirth rose from 0.08% in the first half of 2018 to 1.9% by the first quarter of 2025 — a 24-fold increase.
Women with type 2 diabetes had the highest rate of GLP-1 prescriptions. Among them, use increased from 2.3% to 16.9% over the study period — roughly 1 in 6 women.
Prescribing also increased among women who had gestational diabetes, rising from 0.4% in mid-2021 to 2.7% in the first quarter of 2025. Gestational diabetes affects about 5% to 9% of pregnancies and substantially increases the risk of developing type 2 diabetes later.
The fastest relative increase was seen among women diagnosed with obesity or overweight before pregnancy. GLP-1 use in this group rose from 0.4% in the second half of 2021 to 3.9% by the first quarter of 2025.
Since the second half of 2024, women with diagnosed obesity or overweight have accounted for 40% of new postpartum GLP-1 prescriptions.
Another 21% of women had no documented qualifying diagnosis before giving birth. However, most of these women received a diagnosis — usually obesity or overweight — before starting a GLP-1 medication.
Patients are advised to stop using GLP-1 medications during pregnancy. Most postpartum women in the study who started a GLP-1 did so at least three months after giving birth.
“Postpartum is a critical window for addressing metabolic risk after pregnancy, and we're seeing GLP-1 use explode in this population. Because evidence on GLP-1 exposure during breastfeeding remains limited, rising postpartum initiation warrants further study,” said lead author and Schaeffer scholar Sih-Ting Cai.
A 2025 JAMA study found a similar rise in Denmark. Fewer than five GLP-1 prescriptions per 10,000 women were recorded after childbirth in 2018, rising to 173 per 10,000 by 2024 — nearly 2% of new mothers.
GLP-1s are increasingly used for postpartum weight loss, but their safety after childbirth remains poorly studied. According to researchers, little is known about how these drugs affect normal postpartum hormonal changes or maternal recovery.
They also noted that evidence on GLP-1 exposure during breastfeeding remains limited, highlighting the need for further research as postpartum use increases.
“We simply do not know how weight-loss medication interacts with those processes or whether it could affect normal physiological recovery,” Dr. Jonathan Zipursky, a clinical pharmacologist and toxicologist at the University of Toronto, told The New York Times in 2025.
Evidence on GLP-1s during breastfeeding is also limited. A 2024 CMAJ paper suggested low breast-milk exposure, but researchers stressed that infant safety data remain insufficient. Zipursky recommended avoiding GLP-1s while breastfeeding as a precaution.
© $2026 Times Horizon Private Limited